Chip NMR biosensor for molecular analysis of cells
Principal Investigator: R Weissleder
Affiliation: Harvard University
Abstract: One of the major challenges in medicine is the rapid and accurate measurement of protein bio- markers, cells and organisms in different biological samples. During the prior funding period we had developed a broadly applicable, novel, point-of-care diagnostic platform using "magnetic relaxation switches" as a proximity sensor to amplify molecular interactions. We have shown that highly sensitive and selective measurements (e.g. DNA, mRNA, proteins, metabolites, drugs, bacteria, cells) can be obtained on small volume of unprocessed biological samples. One of the critical limitations of the approach however, was the need for bulky and/or complex NMR systems to carry out the measurements. We have now achieved a technological breakthrough by miniaturizing an entire NMR system onto a single, integrated circuit (IC) chip (dubbed DMR for "diagnostic magnetic resonance"). In preliminary feasibility experiments, we have shown that we can already achieve detection sensitivities of 10-12 M surpassing those of many traditional, time consuming assays. The goal of this competing renewal is to further mature DMR into a cutting-edge detection technology and apply it to molecular and cellular sensing and profiling of cells. Using cancer cells as a specific sensing target, we propose three specific aims to refine and further validate the DMR technology: 1) optimize particle constructs for high efficiency detection of cancer cells; 2) determine the detection threshold and specificity for cancer cells and 3) develop real time molecular analysis of cells in biological samples. This proposal addresses a number of unmet needs and aims at optimizing, validating and further improving the novel DMR biodetection platform. PUBLIC HEALTH RELEVANCE: We are developing a handheld sensor to quickly assay blood and tissue samples in cancer patients. Based on fundamentally new designs, this technology allows sensing and rapid profiling of cancer cells in blood.
Funding Period: 2004-09-01 - 2011-08-31
more information: NIH RePORT
- Protamine as an efficient membrane-translocating peptideFred Reynolds
Center for Molecular Imaging Research, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02129, USA
Bioconjug Chem 16:1240-5. 2005..In addition, the fluorescent protamines developed here might be used to further our understanding of this important pharmaceutical...
- A multifunctional single-attachment-point reagent for controlled protein biotinylationElisabeth Garanger
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Boston, Massachusetts 02129, USA
Bioconjug Chem 20:170-3. 2009..The MSAP peptide-scaffold approach allows fluorophores, chromophores, or reactive groups to be combined with biotin and provides a broad approach to obtain multifunctional biotin-based reagents...
- Electrode chemistry yields a nanoparticle-based NMR sensor for calciumSonia Taktak
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129, USA
Langmuir 24:7596-8. 2008..Our work suggests that the many chemistries of nonbiological origin, such as those employed for ion-selective electrodes, can be adapted to obtain NMR-based sensors for ions...
- Sensitive NMR sensors detect antibodies to influenzaIsaac Koh
Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Boston, MA 02129, USA
Angew Chem Int Ed Engl 47:4119-21. 2008
- Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applicationsDavid E Sosnovik
Center for Molecular Imaging Research, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA
Basic Res Cardiol 103:122-30. 2008..First generation MNP are already in clinical use and second generation agents, with longer blood half lives, are likely to be approved for routine clinical use in the near future...
- Magnetic microparticle aggregation for viscosity determination by MRRui Hong
Center for Molecular Imaging Research, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
Magn Reson Med 59:515-20. 2008....
- Multiparameter magnetic relaxation switch assaysSonia Taktak
Center for Molecular Imaging Research and Department of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA
Anal Chem 79:8863-9. 2007..The T1/T2 and T2 replication interrogation methods illustrate how MRSw assays can employ multiple parameters, instead of relying only on T2, to obtain information about the reaction of NPs with molecular targets...
- Molecular magnetic resonance imaging in cardiovascular medicineDavid E Sosnovik
Center for Molecular Imaging Research, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129, USA
Circulation 115:2076-86. 2007
- Cell internalization of magnetic nanoparticles using transfection agentsKarin Montet-Abou
Center for Molecular Imaging Research Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
Mol Imaging 6:1-9. 2007..Conditions for loading cells with Feridex and a TFA need to be carefully selected to minimize nanoparticle precipitation and dextran adsorption to the cell surface...
- Continuous analyte sensing with magnetic nanoswitchesEric Yi Sun
Center for Molecular Imaging Research, Massachusetts General Hospital, Building 149, 13th St, Room 5410, Charlestown, MA 02129, USA
Small 2:1144-7. 2006
- Wortmannin-C20 conjugates generate wortmanninHushan Yuan
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA
J Med Chem 49:740-7. 2006....
- Transfection agent induced nanoparticle cell loadingKarin Montet-Abou
Center for Molecular Imaging Research and Harvard Medical School, Charlestown, MA 02129, USA
Mol Imaging 4:165-71. 2005..However, we found that the conditions used to label cells with Feridex and transfection agents need to be carefully selected to avoid the problems of surface adsorption and nanoparticle precipitation...
- Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensorsMoritz Wildgruber
Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
PLoS ONE 4:e5663. 2009....